Transcriptional Regulation of Angiotensinogen Gene
Transcriptional Regulation of Angiotensinogen Gene
批准号:
8116623
负责人:
ASHOK KUMAR
金额:
$16.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2011-09-30
关键词:
AcuteAcute-Phase ProteinsAdultAffectAfrican AmericanAgingAllelesAmericanAngiotensin IIAngiotensinogenBindingBlood PressureCCAAT-Enhancer-Binding ProteinsCaucasiansCaucasoid RaceDevelopmentDexamethasoneEssential HypertensionFamilyFrequenciesGene ExpressionGene FrequencyGenesGenetic PolymorphismGenetic TranscriptionGenetic TranslationGlucocorticoidsHaplotypesHealthHeart failureHepatocyteHumanHypertensionIncidenceInflammationInterleukin-6Japanese PopulationKidney FailureKnock-in MouseLeftLiverMessenger RNAMolecularMyocardial InfarctionNucleosidesPatientsPhasePlasmaPlayPopulationPrevalencePromoter RegionsProteinsRecombinantsReninRenin-Angiotensin SystemReporterRisk FactorsRoleSiteStrokeTissuesTranscriptional RegulationTransfectionTransgenic MiceVariantVascular Diseasesblood pressure regulationin vivomalepromotertranscription factorvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hypertension is a serious risk factor for myocardial infarction, heart failure, vascular disease, stroke, and renal failure. The renin-angiotensin system plays an important role in the regulation of blood pressure. Previous studies have suggested that: (a) angiotensinogen (AGT) gene locus is associated with human essential hypertension, (b) variant -6A of the AGT gene is associated with hypertension in Caucasian and Japanese subjects and (c) over-expression of the AGT gene increases blood pressure in transgenic mice. We have found an A/G polymorphism at -217 in the human AGT gene promoter and have shown that frequency of allele A at -217 is significantly increased in African-American hypertensive patients. AGT gene is primarily expressed in the liver and we have shown that reporter constructs containing AGT gene promoter with nucleoside A at -217 have increased basal and IL-6 induced promoter activity on transient transfection in human liver cells. Although hAGT gene has seven polymorphic sites in 1.2Kb region of its promoter, variants -217A almost always occurs with -532T, -793A, and -1074T and variants -217G, -532C, -793G, and -1074G always occur together forming two haplotypes. Since allele - 6A is the predominant allele (frequency 0.85) in African-Americans, AGT gene can be subdivided into four haplotypes -6A:-217A (AA); -6A:-217G (AG); -6G:-217A (GA) and -6G:-217G (GG). However, haplotypes GA and GG are very rare leaving AA and AG as two prominent haplotypes. We have shown that: (a) frequency of AA haplotype is increased in hypertensive patients as compared to the AG haplotype and (b) reporter constructs containing AA haplotype have increased basal as well as IL-6 induced promoter activity as compared to AG haplotype. Since inflammation plays an important role in hypertension, our hypothesis is that increased transcription of AA haplotype of the AGT gene plays an important role in the development of hypertension. In order to prove this hypothesis, we have generated transgenic mice containing human renin gene and either AA or AG haplotype of the hAGT gene using knock-in strategy at the HPRT locus. We have shown that AGT mRNA and protein level is increased in double transgenic mice containing AA haplotype of the AGT gene as compared to the AG haplotype. We have also shown that double transgenic mice containing AA haplotype of the hAGT gene and hRen gene have increased blood pressure as compared to transgenic mice containing AG haplotype of the hAGT gene and hRen gene. We will now study the role of these haplotypes on blood pressure regulation in an in vivo situation in transgenic mice containing either AA or AG haplotype of the hAGT gene and hRen gene but devoid of mAGT gene. PUBLIC HEALTH RELEVANCE: Hypertension is a serious risk factor for myocardial infarction, heart failure, vascular disease, stroke, and renal failure. It is estimated that hypertension affects 50 million Americans with a prevalence rate of 25-30% in the adult Caucasian population. The incidence of hypertension and complications due to hypertension are even greater in the African American population. Our studies will help us understand molecular mechanism involved in hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
-
批准号:10660397
-
项目类别:
-
资助金额:$55.16万
-
财政年份:2023
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1 signaling in skeletal muscle
-
批准号:10201515
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2019
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1 signaling in skeletal muscle
-
批准号:10005646
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2019
-
负责人:ASHOK KUMAR
-
依托单位:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
-
批准号:9197334
-
项目类别:
-
资助金额:$61.5万
-
财政年份:2016
-
负责人:ASHOK KUMAR
-
依托单位:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
-
批准号:9325162
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2016
-
负责人:ASHOK KUMAR
-
依托单位:
MYD88 Signaling in Mammalian Myoblast Fusion
-
批准号:9144184
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2015
-
负责人:ASHOK KUMAR
-
依托单位:
MYD88 Signaling in Mammalian Myoblast Fusion
-
批准号:9336240
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2015
-
负责人:ASHOK KUMAR
-
依托单位:
Aldosterone Synthase & Hypertension
-
批准号:9052214
-
项目类别:
-
资助金额:$22.24万
-
财政年份:2014
-
负责人:ASHOK KUMAR
-
依托单位:
Aldosterone Synthase and Hypertension
-
批准号:8673375
-
项目类别:
-
资助金额:$63.24万
-
财政年份:2014
-
负责人:ASHOK KUMAR
-
依托单位:
Aldosterone Synthase & Hypertension
-
批准号:8837685
-
项目类别:
-
资助金额:$62.29万
-
财政年份:2014
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8502172
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8302314
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8286234
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8392241
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8690762
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8188803
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8106684
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8585083
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Transcriptional Regulation of Angiotensinogen Gene
-
批准号:8476249
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2009
-
负责人:ASHOK KUMAR
-
依托单位:
Transcriptional Regulation of Angiotensinogen Gene
-
批准号:8413074
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2009
-
负责人:ASHOK KUMAR
-
依托单位:
海外基金